A Real-world Study of Obinutuzumab-based Therapy for Previously Untreated FL

NCT05899621 · clinicaltrials.gov ↗

RECRUITING

Status

332

Enrollment

OTHER

Sponsor class

Conditions

Follicular Lymphoma

Interventions

DRUG: Obinutuzumab
DRUG: Lenalidomide
DRUG: Bendamustine
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Prednisone

Sponsor

Ruijin Hospital